Close

Rosetta Genomics' (ROSG) Kidney Cancer Test Approved in New York

July 22, 2014 9:35 AM EDT Send to a Friend
Rosetta Genomics (Nasdaq: ROSG) announced that the New York State Department of Health ("NYSDOH") has given the Company final approval ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login